# Erlotinib

NDC: 0093-7662
Generic name: Erlotinib
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20211208

FDA application: ANDA091059

## Active ingredients

- ERLOTINIB HYDROCHLORIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-7662"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-7662
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d97f401-4853-4a9a-907d-21e8a4d16088